Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Cambridge glioma trial of misonidazole and radiation therapy with associated pharmacokinetic studies

Journal Article · · Cancer Clin. Trials; (United States)
OSTI ID:6059688
Fifty-five patients with grade 3 and 4 supratentorial astrocytomas, were randomized into a three-limb study. At 9 months after the last treatment there were no differences in survival between the treatment groups. No cases of peripheral neuropathy were seen. Investigations into the possible cause of this are presented. It is thought that microsomal enzyme induction by the anticonvulsants phenobarbitone and phenytoin resulted in increased 0-demethylation of the misonidazole. Clinical data to confirm this view are presented. Current MRC protocols of misonidazole studies on gliomas and carcinomas of the cervix and head and neck are summarized.
OSTI ID:
6059688
Journal Information:
Cancer Clin. Trials; (United States), Journal Name: Cancer Clin. Trials; (United States) Vol. 3:3; ISSN CCTRD
Country of Publication:
United States
Language:
English